TEVA PHARMACEUTICAL INDUSTRIES LTD Research And Development Expense

Quick Answer

TEVA PHARMACEUTICAL INDUSTRIES LTD reported Research And Development Expense of $114.00 million for the year ending 2018.

  • TEVA PHARMACEUTICAL INDUSTRIES LTD showed a decrease of -34.9% in Research And Development Expense from 2017 to 2018.
  • This data is from TEVA PHARMACEUTICAL INDUSTRIES LTD's annual report (Form 10-K), filed with the SEC on February 21, 2020.
  • XBRL data for this metric is available from 2011 to 2018 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 8 years of available data (2011 to 2018), TEVA PHARMACEUTICAL INDUSTRIES LTD's Research And Development Expense has grown by 660.0%.
  • Historical annual values: Fiscal year 2018: $114.00 million | Fiscal year 2017: $175.00 million | Fiscal year 2016: $422.00 million | Fiscal year 2015: $35.00 million | Fiscal year 2014: $0.00 | Fiscal year 2013: $5.00 million | Fiscal year 2012: $73.00 million | Fiscal year 2011: $15.00 million.
  • Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: